Literature DB >> 23086303

Association of the apolipoprotein M gene polymorphisms and serum lipid levels.

Lynn Htet Htet Aung1, Rui-Xing Yin, Dong-Feng Wu, Ting-Ting Yan, Qing Li, Jin-Zhen Wu, Wei-Xiong Lin, Cheng-Wu Liu, Shang-Ling Pan.   

Abstract

The association of rs707921 and rs707922 SNPs in the apolipoprotein M (APOM) gene and serum lipid levels is still controversial. This study aimed to detect the association of the APOM rs707921 and rs707922 SNPs and several environmental factors with serum lipid profiles. Genotyping of rs707921 and rs707922 was performed in 703 of Mulao's and 707 of Han's participants. The serum levels of TG in Mulao, and TG and HDL-C in Han were different between the A and C allele carriers of rs707921 (P < 0.05-0.01); while the serum levels of TG in both Mulao and Han were different between the T and G allele carriers of rs707922 (P < 0.05-0.01). According to the gender-subgroup analysis, the levels of TC in Mulao females, TG and ApoB in Han males, and HDL-C in Han females were associated with the genotypes of rs707921 (P < 0.05 for each); whereas the levels of TG in Mulao males, and TG and ApoB in Han males were correlated with the genotypes of rs707922 (P < 0.05 for each). Serum lipid parameters were also associated with several environmental factors (P < 0.05-0.001). The APOM gene rs707921 and rs707922 SNPs are associated with some serum lipid parameters in the two ethnic groups, but the trends of association suggest that the two SNPs might have racial/ethnic- and/or gender- specificity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086303     DOI: 10.1007/s11033-012-2240-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  WHO publishes definitive atlas on global heart disease and stroke epidemic.

Authors: 
Journal:  Indian J Med Sci       Date:  2004-09

2.  Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations.

Authors:  Yin Ruixing; Deng Jiaqiang; Yang Dezhai; Lin Weixiong; Pan Shangling; Wu Jinzhen; Huang Jiandong; Long Xiuyan
Journal:  Kidney Blood Press Res       Date:  2006-11-13       Impact factor: 2.687

3.  Dietary fatty acids and progression of coronary artery disease in men.

Authors:  G F Watts; P Jackson; V Burke; B Lewis
Journal:  Am J Clin Nutr       Date:  1996-08       Impact factor: 7.045

4.  Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.

Authors:  Xian-sheng Huang; Shui-ping Zhao; Min Hu; Yang-ping Luo
Journal:  Med Hypotheses       Date:  2007-01-10       Impact factor: 1.538

Review 5.  Dietary influences on serum lipids and lipoproteins.

Authors:  S M Grundy; M A Denke
Journal:  J Lipid Res       Date:  1990-07       Impact factor: 5.922

6.  Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes.

Authors:  Odilia I Bermudez; Wanda Velez-Carrasco; Ernst J Schaefer; Katherine L Tucker
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

7.  [Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population].

Authors:  Beifan Zhou
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2002-02

8.  Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study.

Authors:  R B Shekelle; A M Shryock; O Paul; M Lepper; J Stamler; S Liu; W J Raynor
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

9.  Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.

Authors:  Josefin Ahnström; Olof Axler; Matti Jauhiainen; Veikko Salomaa; Aki S Havulinna; Christian Ehnholm; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Björn Dahlbäck
Journal:  J Lipid Res       Date:  2008-05-19       Impact factor: 5.922

10.  Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.

Authors:  Jun-Wei Zhou; Stephen K W Tsui; Maggie C Y Ng; Hua Geng; Sai-Kam Li; Wing-Yee So; Ronald C Ma; Ying Wang; Qian Tao; Zhen-Yu Chen; Juliana C N Chan; Yuan-Yuan Ho
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

View more
  6 in total

1.  The relationship between genetic polymorphisms in apolipoprotein E (ApoE) gene and osteonecrosis of the femoral head induced by steroid in Chinese Han population.

Authors:  Lin Yuan; Wei Li; Xianquan Wang; Guang Yang; Haiyang Yu; Shui Sun
Journal:  Genes Genomics       Date:  2017-11-01       Impact factor: 1.839

2.  Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages.

Authors:  Shuang Yao; Fan Zheng; Yang Yu; Yuxia Zhan; Ning Xu; Guanghua Luo; Lu Zheng
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

3.  Sex-specific association of the zinc finger protein 259 rs2075290 polymorphism and serum lipid levels.

Authors:  Lynn Htet Htet Aung; Rui-Xing Yin; Dong-Feng Wu; Wei Wang; Jin-Zhen Wu; Cheng-Wu Liu
Journal:  Int J Med Sci       Date:  2014-03-16       Impact factor: 3.738

4.  Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia.

Authors:  Lynn Htet Htet Aung; Rui-Xing Yin; Dong-Feng Wu; Wei Wang; Cheng-Wu Liu; Shang-Ling Pan
Journal:  J Cell Mol Med       Date:  2014-04-30       Impact factor: 5.310

Review 5.  Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.

Authors:  C S Paththinige; N D Sirisena; Vhw Dissanayake
Journal:  Lipids Health Dis       Date:  2017-06-02       Impact factor: 3.876

6.  Association between the MLX interacting protein-like, BUD13 homolog and zinc finger protein 259 gene polymorphisms and serum lipid levels.

Authors:  Lynn-Htet-Htet Aung; Rui-Xing Yin; Jin-Zhen Wu; Dong-Feng Wu; Wei Wang; Hui Li
Journal:  Sci Rep       Date:  2014-07-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.